Xenetic Biosciences(XBIO) - 2024 Q3 - Quarterly Results

Financial Results - Xenetic Biosciences, Inc. reported financial results for the three months ended September 30, 2024, with a focus on business updates[3] - The press release detailing the financial results is included as Exhibit 99.1, which is referenced in the report[4] Risks and Uncertainties - The company emphasizes that forward-looking statements are subject to risks and uncertainties, including market factors and regulatory processes[5] Management - The report was signed by James Parslow, Interim Chief Executive Officer & Chief Financial Officer, on November 13, 2024[7]